Amid Debt Pressure, Sun Pharma's Research Arm SPARC Plans 40% Workforce Reduction Parthika Patel9 Jan 2026 3:12 PM ISTThe latest restructuring is expected to result in annual cost savings of approximately USD 10 million.
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal sheeba farhat9 Jan 2026 2:59 PM ISTNew Delhi: Merck is in talks to buy cancer drug developer Revolution Medicines in a USD 28 billion to USD 32 billion deal, the Financial Times...
Eli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx Buyout sheeba farhat9 Jan 2026 2:53 PM ISTThis is Lilly's first major transaction of 2026, following a year when its market value topped USD 1 trillion on surging sales of GLP-1 drugs...
Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution Farhat Nasim8 Jan 2026 6:08 PM ISTOlopatadine Hydrochloride Ophthalmic Solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis, a common...
Torrent Pharma to Raise Up to Rs 12,500 Cr via Bonds for JB Chemicals Deal sheeba farhat8 Jan 2026 5:18 PM ISTThe bond sale would be the largest rated fund-raising so far this financial year, which runs from April to March, extending a trend of acquisitions...
DCA Raids Illegal Clinic in Telangana, Seizes Antibiotics, Steroids Parthika Patel8 Jan 2026 5:08 PM ISTHanamkonda: In a crackdown on illegal medical practice, officials of the Drugs Control Administration (DCA), Telangana, conducted a raid on the...
CCTV Mandate at Pharmacies for Schedule Drugs in Delhi Draws Objections from RDCA Parthika Patel8 Jan 2026 4:36 PM ISTNew Delhi: Pharmacists and retail chemists in the national capital have raised strong objections to district-level orders mandating the installation...
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules' Generic Amphetamine XR Farhat Nasim8 Jan 2026 3:11 PM ISTHyderabad: Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, has received tentative approval (TA) from the U.S....
KEAM 2026 Registration Opens for BPharm Admissions in Kerala Parthika Patel8 Jan 2026 3:00 PM ISTThiruvananthapuram: The Commissioner for Entrance Examinations (CEE), Kerala, has commenced the KEAM 2026 registration process for candidates seeking...
Cipla Partner Pharmathen Receives 9 USFDA Observations Farhat Nasim7 Jan 2026 8:22 PM ISTCipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.
JB Chemicals to Infuse Up to Rs 18 Crore into Dubai Arm Unique Pharma Labs Farhat Nasim7 Jan 2026 4:54 PM IST"The additional investment in equity shares of UPL FZE would be utilized towards operational requirements of UPL FZE," the company said.
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs Parthika Patel7 Jan 2026 4:37 PM ISTThese products are among the largest oncology biologics expected to lose exclusivity over the next five years.
